Should hyperbaric oxygen be added to treatment in idiopathic sudden sensorineural hearing loss?

  • Ebru Topuz
  • Ozgur Yigit
  • Ugur Cinar
  • Huseyin Seven


At present, there is still no agreement about the therapy of idiopathic sudden sensorineural hearing loss (ISSHL). Hyperbaric oxygen (HBO) is used in the therapy of ISSHL to increase the partial oxygen pressure and the oxygen concentration in the inner ear and also to improve the blood profile and the microcirculation. In our prospective randomized study, we aimed to investigate the therapeutic effects of HBO therapy in the 1st 2 weeks of the onset of ISSHL. Fifty-one hospitalized patients with confirmed ISSHL who had received therapy were grouped randomly into two groups. Twenty-one patients (group I) received steroids, plasma expander dextrans (rheomacrodex), diazepam, pentoxiphylline and salt restriction, and 30 patients (group II) received the same basic treatment with the addition of HBO therapy. Audiological assessments of the patients were performed before and after the treatment. The hearing gains at frequencies of 250, 500, 1,000, 2,000 and 4,000 Hz were calculated separately. The level of hearing loss at the five frequencies was assessed in three groups at the first visit: equal or below 60 dB, between 61–80 dB and equal or above 81 dB. The average of the mean hearing gains at the five frequencies of the patients according to the age groups in group II was compared. The mean hearing gains at the five frequencies were compared between the two groups, and statistically significant improvement was detected in all the frequencies except at 2,000 Hz in group II. The mean hearing gains in group II were found to be significantly high in patients with initial hearing levels up to 60 dB in comparison to patients with initial hearing levels below 60 dB. When age groups and mean hearing gains were compared, there was no statistically significant difference in group I. In group II, the mean hearing gains were 39.1±18.3 dB in patients younger than 50 years and 22.7±11.3 dB in patients older than 50 years (P=0.044). In conclusion, the addition of HBO therapy to conventional treatment modalities significantly improves the outcome of ISSHL, especially at the frequencies of 250, 500, 1,000 and 4,000 Hz and in hearing loss of above 61 dB. Furthermore, HBO therapy was found to be more effective in patients younger than 50 years.


Sudden hearing loss Hyperbaric oxygen Treatment 


  1. 1.
    Appaix A, Demard F (1970) Hyperbaric oxygenotherapy and sudden perceptive deafness. Rev Laryngol Otol Rhinol (Bord) 91:951–972Google Scholar
  2. 2.
    Aslan I, Oysu C, Veyseller B, Baserer N (2002) Does the addition of hyperbaric oxygen therapy to the conventional treatment modalities influence the outcome of sudden deafness? Otolaryngol Head Neck Surg 126:121–126CrossRefPubMedGoogle Scholar
  3. 3.
    Goto F, Fujita T, Kitani Y, Kanno M, Kamei T, Ishii H (1979) Hyperbaric oxygen and stellate ganglion blocks for idiopathic sudden hearing loss. Acta Otolaryngol 88:335–342PubMedGoogle Scholar
  4. 4.
    Hughes GB (1998) Sudden hearing loss. In: Gates GA (ed) Current herapy in otolaryngology-head and neck surgery, 6th edn. Mosby, St. Louis, p 41Google Scholar
  5. 5.
    Lamm H, Klimpel L (1971) Hyperbaric oxygen therapy in internal ear and vestibular disorders. Preliminary report. HNO 19:363–369PubMedGoogle Scholar
  6. 6.
    Lamm C, Walliser U, Schumann K, Lamm K (1988) Oxygen partial pressure measurements in the perilymph and scala tympani in normo- and hyperbaric conditions. An animal experiment study. HNO 36:363–366PubMedGoogle Scholar
  7. 7.
    Lamm K, Lamm H, Arnold W (1998) Effect of hyperbaric oxygen therapy in comparison to conventional or placebo therapy or no treatment in idiopathic sudden hearing loss, acoustic trauma, noise-induced hearing loss and tinnitus. A literature survey. Adv Otorhinolaryngol 54:86–99PubMedGoogle Scholar
  8. 8.
    Lamm K, Lamm C, Arnold W (1998) Effect of isobaric oxygen versus hyperbaric oxygen on the normal and noise-damaged hypoxic and ischemic guinea pig inner ear. Adv Otorhinolaryngol 54:59–85PubMedGoogle Scholar
  9. 9.
    Nagahara K, Fisch U, Yagi N (1983) Perilymph oxygenation in sudden and progressive sensorineural hearing loss. Acta Otolaryngol 96:57–68PubMedGoogle Scholar
  10. 10.
    Nakashima T, Fukuta S, Yanagita N (1998) Hyperbaric oxygen therapy for sudden deafness. Adv Otorhinolaryngol 54:100–109PubMedGoogle Scholar
  11. 11.
    Pilgramm M, Lamm H, Schumann K (1985) Hyperbaric oxygen therapy in sudden deafness Laryngol Rhinol Otol (Stuttg) 64:351–354Google Scholar
  12. 12.
    Takahashi H, Kobayashi S (1998) New indications for hyperbaric oxygen therapy and its complication. Adv Otorhinolaryngol 54:1–13PubMedGoogle Scholar
  13. 13.
    Vincey P (1978) Application and use of hyperbaric oxygenation in ENT. Rev Laryngol Otol Rhinol (Bord) 99:619–634Google Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Ebru Topuz
    • 1
  • Ozgur Yigit
    • 1
    • 2
  • Ugur Cinar
    • 1
  • Huseyin Seven
    • 1
  1. 1.Department of OtolaryngologySisli Etfal Teaching and Research HospitalistanbulTurkey
  2. 2.IstanbulTurkey

Personalised recommendations